Implementing prescriber-pharmacist collaboration to improve evidence-based medication prescribing using asynchronous, non-interruptive electronic health record notifications. [PDF]
Barnes GD +8 more
europepmc +1 more source
Ciclopirox Olamine Inhibits the NLRP3 Inflammasome to Alleviate Inflammatory Diseases
There is no drug targeting the NLRP3 inflammasome that has been approved for use in clinical settings. Ciclopirox olamine (CPX), an antifungal agent approved by the US Food and Drug Administration (FDA), is identified as a specific and potent NLRP3 inflammasome inhibitor. CPX targets the NACHT domain of NLRP3 at Y381 to impair NLRP3 oligomerization and
Xinyu Xia +7 more
wiley +1 more source
<i>Letter:</i> Hospice and Palliative Medicine Prescriber Experience and Comfort with Managing Substance Use Disorders. [PDF]
Nowels MA +5 more
europepmc +1 more source
A method to identify prescription drug targets for health technology reassessment. [PDF]
Hofmeister M +4 more
europepmc +1 more source
Adrenaline (epinephrine) nasal spray for severe allergic reactions. [PDF]
europepmc +1 more source
Assessment of High-Volume Antibiotic and Opioid Prescribing by Medicare Part D Prescribers-United States, 2021. [PDF]
Vazquez Deida AA +6 more
europepmc +1 more source
Prevalence and predictors of prescribing errors in a primary care setting in Ghana. [PDF]
Djochie RDA +6 more
europepmc +1 more source
Related searches:

